✦ LIBER ✦

Progression from partial to generalised lipodystrophy — a case report

✍ Scribed by B. Bourke; D. Powell

Book ID: 112946984
Publisher: Springer-Verlag
Year: 1992
Tongue: English
Weight: 276 KB
Volume: 161
Category: Article
ISSN: 1863-4362
DOI: 10.1007/bf02942157

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast augmentation in Familial Partial

Breast augmentation in Familial Partial Lipodystrophy: A case report

✍ Juliana M.F. Hughes; Christopher Stephen; Andrew B. Johnson; Sherif Wilson 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 455 KB

Efficacy of pioglitazone in familial par

Efficacy of pioglitazone in familial partial lipodystrophy of the Dunnigan type: a case report

✍ F. Moreau; S. Boullu-Sanchis; C. Vigouroux; C. Lucescu; O. Lascols; R. Sapin; D. 📂 Article 📅 2007 🏛 Masson Editeur 🌐 French ⚖ 135 KB

Poster 230 Progression to Spondyloptosis

Poster 230 Progression to Spondyloptosis: A Case Report

✍ David J. Perna; Ehsan Abdeshahian; Sanjeev Agarwal; Paul A. Pipia 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 52 KB

Erratum to: Case Report: Unicameral Bone

Erratum to: Case Report: Unicameral Bone Cysts in a Young Patient with Acquired Generalized Lipodystrophy

✍ James M. Gregory; Alexandre Arkader; Aqiba Bokhari; John P. Dormans 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 101 KB

CASE REPORT: Myositis, Microvesicular He

CASE REPORT: Myositis, Microvesicular Hepatitis, and Progression to Cirrhosis from Troglitazone Added to Simvastatin

✍ Stephen H. Caldwell; Elizabeth Erickson Hespenheide; Reid W. von Borstel 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 47 KB

Dendrimers: From Design to Application—A

Dendrimers: From Design to Application—A Progress Report

✍ Marco Fischer; Fritz Vögtle 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 883 KB

A unique combination of a clearly defined particle structure and a very highly functionalized surface is offered by the topical dendrimers. Many groups work on this unusual molecular architecture to develop new applications. The most advanced progress in this respect is an MRI contrast agent based o